We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMNX
1726
DELISTED
Luminex Corp
LMNX
– –
-13,762
Closed -$284K
MSGN
1727
DELISTED
MSG Networks Inc.
MSGN
– –
-95,032
Closed -$1.54M
BPFH
1728
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
– –
-45,585
Closed -$531K
CATM
1729
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
– –
-2,391
Closed -$73K
CMD
1730
DELISTED
Cantel Medical Corporation
CMD
– –
-1,832
Closed -$137K
AEGN
1731
DELISTED
Aegion Corp
AEGN
– –
-13,155
Closed -$281K
NBLX
1732
DELISTED
Noble Midstream Partners LP
NBLX
– –
-13,859
Closed -$335K
RP
1733
DELISTED
RealPage, Inc.
RP
– –
-651
Closed -$41K
SMTX
1734
DELISTED
SMTC Corporation
SMTX
– –
-24,294
Closed -$52K
UROV
1735
DELISTED
Urovant Sciences Ltd.
UROV
– –
-2,567
Closed -$24K
SINA
1736
DELISTED
Sina Corp
SINA
– –
-5,911
Closed -$232K
TCP
1737
DELISTED
TC Pipelines LP
TCP
– –
-2,407
Closed -$98K
FBM
1738
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
– –
-279,871
Closed -$4.33M
NGHC
1739
DELISTED
National General Holdings Corp
NGHC
– –
-1,504
Closed -$35K
DNKN
1740
DELISTED
Dunkin' Brands Group, Inc.
DNKN
– –
-88,051
Closed -$6.99M
CBL
1741
DELISTED
CBL& Associates Properties, Inc.
CBL
– –
-48,627
Closed -$63K
AIMT
1742
DELISTED
Aimmune Therapeutics
AIMT
– –
-272,536
Closed -$5.71M
MNK
1743
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-318,296
Closed -$767K
PFNX
1744
DELISTED
Pfenex Inc.
PFNX
– –
-5,685
Closed -$48K
TLRD
1745
DELISTED
Tailored Brands, Inc.
TLRD
– –
-37,077
Closed -$163K
GCAP
1746
DELISTED
Gain Capital Holdings, Inc.
GCAP
– –
-17,484
Closed -$92K
CHK
1747
DELISTED
Chesapeake Energy Corporation
CHK
– –
-23
Closed -$6K
AXE
1748
DELISTED
Anixter International Inc
AXE
– –
-9,222
Closed -$637K
STML
1749
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-9,223
Closed -$96K
WBC
1750
DELISTED
WABCO HOLDINGS INC.
WBC
– –
-102
Closed -$14K
68 69
70
71 72

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.